| Q37709583 | Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity. |
| Q35232109 | CB(1) cannabinoid receptors and their associated proteins |
| Q55252194 | Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. |
| Q30573949 | Cannabinoid receptor activation reduces TNFalpha-induced surface localization of AMPAR-type glutamate receptors and excitotoxicity. |
| Q37152051 | Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium |
| Q42872711 | Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. |
| Q37286102 | Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells |
| Q38222889 | Cannabinoids: well-suited candidates for the treatment of perinatal brain injury. |
| Q38560061 | Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System |
| Q37718540 | Control of intracellular calcium signaling as a neuroprotective strategy |
| Q39969705 | Disruption of IFN-gamma- mediated antiviral activity in neurons: the role of cannabinoids |
| Q48750345 | Distinct regulation of nNOS and iNOS by CB2 receptor in remote delayed neurodegeneration |
| Q39635515 | Dual Neuroprotective and Neurotoxic Effects of Cannabinoid Drugs in Vitro |
| Q37015432 | Endocannabinoids and reactive nitrogen and oxygen species in neuropathologies. |
| Q37364657 | HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity |
| Q36975934 | Inhibition of a SNARE-sensitive pathway in astrocytes attenuates damage following stroke |
| Q33697608 | Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke |
| Q33772042 | Neuroprotective therapies after perinatal hypoxic-ischemic brain injury |
| Q36374839 | New horizons for newborn brain protection: enhancing endogenous neuroprotection |
| Q33446413 | Possible Anandamide and Palmitoylethanolamide involvement in human stroke |
| Q37375454 | Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy |
| Q48249612 | Reciprocal Connections Between Cortex and Thalamus Contribute to Retinal Axon Targeting to Dorsal Lateral Geniculate Nucleus |
| Q36247115 | Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke |
| Q30470076 | Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. |
| Q37444391 | Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons |
| Q40961956 | The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia. |
| Q37306525 | The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801 |
| Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
| Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |
| Q38156518 | The influence of cannabinoids on generic traits of neurodegeneration |
| Q38248001 | Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury |
| Q33638542 | Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity |